| Literature DB >> 7913101 |
D C Mangham1, D C Rowlands, K M Newbold, G M Reynolds, J W Fielding, M T Hallissey.
Abstract
It has been proposed that immunostaining with PC10, a monoclonal antibody against proliferating cell nuclear antigen (PCNA), is of prognostic value in gastric carcinoma. Gastric carcinomas from a series of 90 patients in whom survival data were known have been studied. There was no relation between the degree of PC10 immunostaining assessed semiquantitatively and survival.Entities:
Mesh:
Substances:
Year: 1994 PMID: 7913101 PMCID: PMC502033 DOI: 10.1136/jcp.47.5.473
Source DB: PubMed Journal: J Clin Pathol ISSN: 0021-9746 Impact factor: 3.411